Annual EBITDA:
-$110.33M-$28.43M(-34.71%)Summary
- As of today, URGN annual EBITDA is -$110.33 million, with the most recent change of -$28.43 million (-34.71%) on December 31, 2024.
- During the last 3 years, URGN annual EBITDA has fallen by -$2.74 million (-2.54%).
- URGN annual EBITDA is now -11013.45% below its all-time high of $1.01 million, reached on December 31, 2016.
Performance
URGN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$40.85M-$4.43M(-12.18%)Summary
- As of today, URGN quarterly EBITDA is -$40.85 million, with the most recent change of -$4.43 million (-12.18%) on June 30, 2025.
- Over the past year, URGN quarterly EBITDA has dropped by -$15.28 million (-59.73%).
- URGN quarterly EBITDA is now -392.18% below its all-time high of $13.98 million, reached on December 31, 2016.
Performance
URGN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$121.90M-$15.28M(-14.33%)Summary
- As of today, URGN TTM EBITDA is -$121.90 million, with the most recent change of -$15.28 million (-14.33%) on June 30, 2025.
- Over the past year, URGN TTM EBITDA has dropped by -$43.66 million (-55.81%).
- URGN TTM EBITDA is now -2766.23% below its all-time high of $4.57 million, reached on December 31, 2016.
Performance
URGN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
URGN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -34.7% | -59.7% | -55.8% |
| 3Y3 Years | -2.5% | -124.0% | -48.3% |
| 5Y5 Years | -2.0% | -30.4% | +11.3% |
URGN EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -34.7% | at low | -212.2% | at low | -91.0% | at low |
| 5Y | 5-Year | -34.7% | +11.5% | -212.2% | at low | -91.0% | +11.3% |
| All-Time | All-Time | >-9999.0% | +11.5% | -392.2% | at low | -2766.2% | +11.3% |
URGN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$40.85M(-12.2%) | -$121.90M(-14.3%) |
| Mar 2025 | - | -$36.42M(-33.1%) | -$106.62M(-11.5%) |
| Dec 2024 | -$110.33M(-34.7%) | -$27.35M(-58.3%) | -$95.60M(-16.0%) |
| Sep 2024 | - | -$17.28M(+32.4%) | -$82.43M(-5.4%) |
| Jun 2024 | - | -$25.58M(-0.7%) | -$78.23M(-15.7%) |
| Mar 2024 | - | -$25.39M(-79.0%) | -$67.61M(-5.9%) |
| Dec 2023 | -$81.90M(+16.2%) | -$14.19M(-8.4%) | -$63.83M(+8.1%) |
| Sep 2023 | - | -$13.09M(+12.5%) | -$69.48M(+6.2%) |
| Jun 2023 | - | -$14.95M(+30.8%) | -$74.05M(+4.3%) |
| Mar 2023 | - | -$21.61M(-9.0%) | -$77.33M(-0.1%) |
| Dec 2022 | -$97.77M(+9.1%) | -$19.83M(-12.3%) | -$77.22M(-0.5%) |
| Sep 2022 | - | -$17.65M(+3.2%) | -$76.86M(+6.5%) |
| Jun 2022 | - | -$18.24M(+15.2%) | -$82.19M(+4.8%) |
| Mar 2022 | - | -$21.50M(-10.5%) | -$86.33M(+4.6%) |
| Dec 2021 | -$107.60M(+13.7%) | -$19.46M(+15.3%) | -$90.52M(+7.3%) |
| Sep 2021 | - | -$22.99M(-2.7%) | -$97.69M(+5.5%) |
| Jun 2021 | - | -$22.38M(+12.9%) | -$103.33M(+8.0%) |
| Mar 2021 | - | -$25.69M(+3.6%) | -$112.28M(+10.0%) |
| Dec 2020 | -$124.69M | -$26.64M(+6.9%) | -$124.69M(+9.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$28.63M(+8.6%) | -$137.50M(-4.0%) |
| Jun 2020 | - | -$31.32M(+17.8%) | -$132.26M(-6.1%) |
| Mar 2020 | - | -$38.10M(+3.4%) | -$124.63M(-14.5%) |
| Dec 2019 | -$108.15M(-40.9%) | -$39.44M(-68.6%) | -$108.89M(-16.6%) |
| Sep 2019 | - | -$23.39M(+1.3%) | -$93.42M(-2.6%) |
| Jun 2019 | - | -$23.69M(-5.9%) | -$91.06M(-6.2%) |
| Mar 2019 | - | -$22.37M(+6.7%) | -$85.75M(-11.4%) |
| Dec 2018 | -$76.76M(-288.8%) | -$23.97M(-14.0%) | -$76.96M(-22.0%) |
| Sep 2018 | - | -$21.03M(-14.4%) | -$63.10M(-49.0%) |
| Jun 2018 | - | -$18.38M(-35.3%) | -$42.35M(-42.0%) |
| Mar 2018 | - | -$13.58M(-34.5%) | -$29.83M(-51.1%) |
| Dec 2017 | -$19.74M(-2052.8%) | -$10.10M(-3431.5%) | -$19.74M(-555.0%) |
| Sep 2017 | - | -$286.00K(+95.1%) | $4.34M(+403.9%) |
| Jun 2017 | - | -$5.86M(-67.9%) | -$1.43M(-232.3%) |
| Mar 2017 | - | -$3.49M(-125.0%) | $1.08M(-76.4%) |
| Dec 2016 | $1.01M(+108.2%) | $13.98M(+331.0%) | $4.57M(+148.6%) |
| Sep 2016 | - | -$6.05M(-80.3%) | -$9.41M(-180.3%) |
| Jun 2016 | - | -$3.36M | -$3.36M |
| Dec 2015 | -$12.30M | - | - |
FAQ
- What is UroGen Pharma Ltd. annual EBITDA?
- What is the all-time high annual EBITDA for UroGen Pharma Ltd.?
- What is UroGen Pharma Ltd. annual EBITDA year-on-year change?
- What is UroGen Pharma Ltd. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for UroGen Pharma Ltd.?
- What is UroGen Pharma Ltd. quarterly EBITDA year-on-year change?
- What is UroGen Pharma Ltd. TTM EBITDA?
- What is the all-time high TTM EBITDA for UroGen Pharma Ltd.?
- What is UroGen Pharma Ltd. TTM EBITDA year-on-year change?
What is UroGen Pharma Ltd. annual EBITDA?
The current annual EBITDA of URGN is -$110.33M
What is the all-time high annual EBITDA for UroGen Pharma Ltd.?
UroGen Pharma Ltd. all-time high annual EBITDA is $1.01M
What is UroGen Pharma Ltd. annual EBITDA year-on-year change?
Over the past year, URGN annual EBITDA has changed by -$28.43M (-34.71%)
What is UroGen Pharma Ltd. quarterly EBITDA?
The current quarterly EBITDA of URGN is -$40.85M
What is the all-time high quarterly EBITDA for UroGen Pharma Ltd.?
UroGen Pharma Ltd. all-time high quarterly EBITDA is $13.98M
What is UroGen Pharma Ltd. quarterly EBITDA year-on-year change?
Over the past year, URGN quarterly EBITDA has changed by -$15.28M (-59.73%)
What is UroGen Pharma Ltd. TTM EBITDA?
The current TTM EBITDA of URGN is -$121.90M
What is the all-time high TTM EBITDA for UroGen Pharma Ltd.?
UroGen Pharma Ltd. all-time high TTM EBITDA is $4.57M
What is UroGen Pharma Ltd. TTM EBITDA year-on-year change?
Over the past year, URGN TTM EBITDA has changed by -$43.66M (-55.81%)